Biondo Investment Advisors’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-115,184
| Closed | -$7.95M | – | 91 |
|
|
2024
Q1 | $7.95M | Buy |
115,184
+2,799
| +2% | +$177K | 1.23% | 33 |
|
|
2023
Q4 | $8.31M | Sell |
112,385
-311
| -0.3% | -$20.4K | 1.41% | 28 |
|
|
2023
Q3 | $7.69M | Buy |
112,696
+3,103
| +3% | +$263K | 1.45% | 25 |
|
|
2023
Q2 | $10.3M | Sell |
109,593
-170
| -0.2% | -$13.3K | 1.9% | 17 |
|
|
2023
Q1 | $7.44M | Buy |
109,763
+6,999
| +7% | +$450K | 1.5% | 29 |
|
|
2022
Q4 | $5.09M | Sell |
102,764
-11,686
| -10% | -$477K | 1.13% | 36 |
|
|
2022
Q3 | $3.72M | Buy |
114,450
+6,852
| +6% | +$283K | 0.86% | 38 |
|
|
2022
Q2 | $4.24M | Buy |
107,598
+2,705
| +3% | +$145K | 0.93% | 37 |
|
|
2022
Q1 | $7.33M | Sell |
104,893
-3,629
| -3% | -$265K | 1.29% | 30 |
|
|
2021
Q4 | $8.45M | Sell |
108,522
-4,659
| -4% | -$411K | 1.41% | 22 |
|
|
2021
Q3 | $10.8M | Buy |
113,181
+392
| +0.3% | +$41.4K | 1.85% | 17 |
|
|
2021
Q2 | $14M | Buy |
112,789
+16,103
| +17% | +$1.92M | 2.41% | 13 |
|
|
2021
Q1 | $12.7M | Buy |
96,686
+7,558
| +8% | +$1.03M | 2.54% | 11 |
|
|
2020
Q4 | $11.8M | Buy |
89,128
+1,346
| +2% | +$163K | 2.26% | 12 |
|
|
2020
Q3 | $8.95M | Buy |
87,782
+124
| +0.1% | +$10.7K | 1.94% | 15 |
|
|
2020
Q2 | $7.62M | Buy |
87,658
+1,652
| +2% | +$132K | 1.92% | 15 |
|
|
2020
Q1 | $4.99M | Sell |
86,006
-67,094
| -44% | -$5.45M | 1.65% | 18 |
|
|
2019
Q4 | $14.2M | Sell |
153,100
-190
| -0.1% | -$16.7K | 3.27% | 9 |
|
|
2019
Q3 | $13.9M | Sell |
153,290
-50,530
| -25% | -$5.76M | 3.54% | 7 |
|
|
2019
Q2 | $24.1M | Buy |
203,820
+7,200
| +4% | +$725K | 5.7% | 4 |
|
|
2019
Q1 | $17M | Buy |
196,620
+37,295
| +23% | +$3.17M | 4.27% | 6 |
|
|
2018
Q4 | $10.1M | Buy |
159,325
+5,615
| +4% | +$385K | 3.03% | 8 |
|
|
2018
Q3 | $12.1M | Buy |
153,710
+41,965
| +38% | +$2.74M | 2.88% | 9 |
|
|
2018
Q2 | $6.68M | Buy |
111,745
+7,065
| +7% | +$380K | 1.68% | 16 |
|
|
2018
Q1 | $4.22M | Buy |
104,680
+9,945
| +10% | +$485K | 1.1% | 30 |
|
|
2017
Q4 | $4.98M | Buy |
94,735
+58,135
| +159% | +$3.1M | 1.26% | 24 |
|
|
2017
Q3 | $1.73M | Buy |
36,600
+9,100
| +33% | +$366K | 0.47% | 48 |
|
|
2017
Q2 | $973K | Buy |
+27,500
| New | +$849K | 0.28% | 56 |
|
|
2016
Q1 | – | Sell |
-11,000
| Closed | -$102K | – | 78 |
|
|
2015
Q4 | $102K | Sell |
11,000
-6,000
| -35% | -$55.8K | 0.03% | 78 |
|
|
2015
Q3 | $306K | Sell |
17,000
-2,000
| -11% | -$45.9K | 0.1% | 73 |
|
|
2015
Q2 | $565K | Buy |
+19,000
| New | +$477K | 0.17% | 60 |
|
|
2015
Q1 | – | Sell |
-25,300
| Closed | -$694K | – | 83 |
|
|
2014
Q4 | $694K | Buy |
+25,300
| New | +$616K | 0.21% | 54 |
|
Other funds holding EXAS
Biondo Investment Advisors's EXAS Position: Q2 2024 in Review
Biondo Investment Advisors sold out of Exact Sciences (EXAS) in Q2 2024, closing a stake of 115,184 shares — an estimated $7.95M sold.
Biondo Investment Advisors first reported a position in EXAS in Q4 2014 and held it in 32 quarters. The position peaked at $24.1M in Q2 2019. 542 funds tracked by Wall St. Rank hold EXAS as of Q2 2024.
- Biondo Investment Advisors reported no remaining Exact Sciences position as of Q2 2024 after selling out during the quarter.
- Biondo Investment Advisors sold 115,184 Exact Sciences shares in Q2 2024, an estimated $7.95M.
- Biondo Investment Advisors first reported a position in Exact Sciences in Q4 2014 and held it in 32 quarters.
- Biondo Investment Advisors's Exact Sciences position peaked at $24.1M in Q2 2019.
- 542 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2024.
Based on Biondo Investment Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.